Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (The TOM Trial): design and methods
- PMID: 18996225
- PMCID: PMC3031114
- DOI: 10.1016/j.cct.2008.10.005
Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (The TOM Trial): design and methods
Abstract
The TOM study is the first, single-site, placebo-controlled, randomized clinical trial designed to comprehensively determine the effects of testosterone administration on muscle strength and physical function in older men with mobility limitations. A total of 252 community dwelling individuals aged 65 and older with low testosterone levels and self-reported limitations in mobility and short physical performance battery (SPPB) scores between 4 and 9 will be randomized to receive either placebo or testosterone therapy for 6 months. The primary objective is to determine whether testosterone therapy improves maximal voluntary muscle strength as quantified by the one repetition maximum. Secondary outcomes will include measures of physical function (walking, stair climbing and a lifting and lowering task), habitual physical activity and self-reported disability. The effects of testosterone on affect, fatigue and sense of well being will also be assessed. Unique aspects of the TOM Trial include selection of men with self-reported as well as objectively demonstrable functional limitations, community-based screening and recruitment, adjustment of testosterone dose to ensure serum testosterone levels in the target range while maintaining blinding, and inclusion of a range of self-reported and performance-based physical function measures as outcomes. Clinicaltrials.gov identifier: NCT00240981.
Similar articles
-
Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation.J Gerontol A Biol Sci Med Sci. 2011 Oct;66(10):1090-9. doi: 10.1093/gerona/glr100. Epub 2011 Jun 22. J Gerontol A Biol Sci Med Sci. 2011. PMID: 21697501 Free PMC article. Clinical Trial.
-
Testosterone does not affect agrin cleavage in mobility-limited older men despite improvement in physical function.Andrology. 2018 Jan;6(1):29-36. doi: 10.1111/andr.12424. Epub 2017 Sep 26. Andrology. 2018. PMID: 28950424 Clinical Trial.
-
Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men.J Am Geriatr Soc. 2008 Nov;56(11):1991-9. doi: 10.1111/j.1532-5415.2008.01927.x. Epub 2008 Sep 15. J Am Geriatr Soc. 2008. PMID: 18795988 Free PMC article. Clinical Trial.
-
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?Endocr Rev. 2012 Jun;33(3):314-77. doi: 10.1210/er.2012-1002. Epub 2012 Mar 20. Endocr Rev. 2012. PMID: 22433122 Free PMC article. Review.
-
Role of testosterone in cognition and mobility of aging men.Andrology. 2020 Nov;8(6):1567-1579. doi: 10.1111/andr.12872. Epub 2020 Aug 31. Andrology. 2020. PMID: 32700462 Review.
Cited by
-
Hypogonadism: Easy to define, hard to diagnose, and controversial to treat.Can Urol Assoc J. 2015 Jan-Feb;9(1-2):65-8. doi: 10.5489/cuaj.2416. Can Urol Assoc J. 2015. PMID: 25737761 Free PMC article. No abstract available.
-
Advances in research on pharmacotherapy of sarcopenia.Aging Med (Milton). 2021 Aug 9;4(3):221-233. doi: 10.1002/agm2.12168. eCollection 2021 Sep. Aging Med (Milton). 2021. PMID: 34553120 Free PMC article. Review.
-
Perioperative Testosterone Supplementation Increases Lean Mass in Healthy Men Undergoing Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial.Orthop J Sports Med. 2017 Aug 9;5(8):2325967117722794. doi: 10.1177/2325967117722794. eCollection 2017 Aug. Orthop J Sports Med. 2017. PMID: 28840147 Free PMC article.
-
Establishing the Link Between Lean Mass and Grip Strength Cut Points With Mobility Disability and Other Health Outcomes: Proceedings of the Sarcopenia Definition and Outcomes Consortium Conference.J Gerontol A Biol Sci Med Sci. 2020 Jun 18;75(7):1317-1323. doi: 10.1093/gerona/glz081. J Gerontol A Biol Sci Med Sci. 2020. PMID: 30869772 Free PMC article.
-
Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation.J Gerontol A Biol Sci Med Sci. 2011 Oct;66(10):1090-9. doi: 10.1093/gerona/glr100. Epub 2011 Jun 22. J Gerontol A Biol Sci Med Sci. 2011. PMID: 21697501 Free PMC article. Clinical Trial.
References
-
- Jette AM, Pinsky JL, Branch LG, Wolf PA, Feinleib M. The Framingham Disability Study: physical disability among community-dwelling survivors of stroke. J Clin Epidemiol. 1988;41(8):719–726. - PubMed
-
- Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988;319(26):1701–1707. - PubMed
-
- Studenski S, Perera S, Wallace D, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc. 2003;51(3):314–322. - PubMed
-
- Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Jama. 1995;273(1):59–65. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources